Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

ΔN-ASPP2, a novel isoform of the ASPP2 tumor suppressor, promotes cellular survival

Journal Article · · Biochemical and Biophysical Research Communications
;  [1];  [1]; ;  [1];  [2];  [1];  [3];  [4]; ; ;  [2]
  1. Department of Medicine, Division of Hematology and Medical Oncology and the Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239 (United States)
  2. Department of Molecular and Medical Genetics and the Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239 (United States)
  3. Shandong Tumor Hospital and Institute, Jinan, 250117 (China)
  4. Department of Surgery and the Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239 (United States)
ASPP2 is a tumor suppressor that works, at least in part, through enhancing p53-dependent apoptosis. We now describe a new ASPP2 isoform, ΔN-ASPP2, generated from an internal transcription start site that encodes an N-terminally truncated protein missing a predicted 254 amino acids. ΔN-ASPP2 suppresses p53 target gene transactivation, promoter occupancy, and endogenous p53 target gene expression in response to DNA damage. Moreover, ΔN-ASPP2 promotes progression through the cell cycle, as well as resistance to genotoxic stress-induced growth inhibition and apoptosis. Additionally, we found that ΔN-ASPP2 expression is increased in human breast tumors as compared to adjacent normal breast tissue; in contrast, ASPP2 is suppressed in the majority of these breast tumors. Together, our results provide insight into how this new ASPP2 isoform may play a role in regulating the ASPP2-p53 axis. - Highlights: • ΔN-ASPP2 is a N-terminal truncated ASPP2 isoform. • ΔN-ASPP2 antagonizes p53 transactivation and p53 promoter occupancy after cellular stress. • ΔN-ASPP2 promotes cell proliferation and suppresses cytotoxic damage-induced growth inhibition and apoptosis. • ΔN-ASPP2 is overexpressed in human breast tumors compared to adjacent normal breast tissue.
OSTI ID:
22696803
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 4 Vol. 482; ISSN 0006-291X; ISSN BBRCA9
Country of Publication:
United States
Language:
English

Similar Records

Repression of estrogen receptor {beta} function by putative tumor suppressor DBC1
Journal Article · Thu Feb 11 23:00:00 EST 2010 · Biochemical and Biophysical Research Communications · OSTI ID:22202370

Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Journal Article · Fri Oct 24 00:00:00 EDT 2008 · Public Library of Science (PLoS) · OSTI ID:945357

Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway
Journal Article · Fri Jun 10 00:00:00 EDT 2016 · Biochemical and Biophysical Research Communications · OSTI ID:22598765